PPT-Evolving Access Pathways for Long-Acting HIV Prevention Products

Shelly Malhotra Senior Director Global Access IAVI No conflicts of interest are declared Coauthors S Malhotra M Keane A Kurzman N Sender M Price IAVI New York United States Evolving Access Pathways for LongActing HIV Prevention Products. David Hubacher, PhD. Senior Epidemiologist. FHI. Outline of Talk. Description of long-acting reversible contraception (LARC). Worldwide use of long-acting. Advantages and Disadvantages. Service delivery factors. landscape . and levers. Perfect Information Pathway Project. Defining. good practice in embedding access to information across patient pathways. Designing . a ‘perfect patient information pathway’ based on findings. Module 5: . State of NPT Research. www.icad-cisd.com. Status of research. What happened with these trials?. Nonoxynol. 9. Savvy. Circumcision. Cellulose . Sulphate. Merck vaccine. CAPRISA 004 (. tenofovir. PrEP. Anton Pozniak . MD FRCP. Consultant Physician . . Disclosures. I have received honoraria, travel sponsorship and research grants from:. Gilead Sciences . Janssen. MSD. ViiV Healthcare. BUT… success depends on adherence.. Tuesday 8. th. November 2016, Jubilee Room,. . House of Commons. . Regulating and paying for regenerative medicine products in the NHS – . challenges and opportunities. Flexibilities in regulation that are part of attempts to accelerate access to market of new products. for PrEP. Sinead Delany-Moretlwe. University of the Witwatersrand. IAS, Amsterdam, July 2018. Women account for more than half of adults living with HIV globally. Young women are twice as likely to be living with HIV as young men. Rachel Pleasants McDonnell. MY . CAREER PATH. JFF:. BUILDING A FUTURE THAT WORKS. OUR WORK. We drive meaningful change in the American workforce and education systems. For 35 years, JFF has led the way in designing innovative and scalable solutions that create access to economic advancement for all.. Cheyenne . McCravey. , M.Ed.. Secondary Falls Prevention Coordinator. Adult Falls Prevention Program. Epidemiology and Response Division. New Mexico Department of Health. Disclosure Statement. Cheyenne McCravey does not have any relevant financial relationships with any commercial interests that creates a conflict of interest to affect CME content about products or services. Get Started with Using Pathways A Beginner’s Guide on using Pathways and where to get help! Ray Rivero DTM 30 March 2019 2 Workshop Objectives Introduction to Pathways How to Access Pathways delivering the ng technologies rapeutics by the potentials e. Dr Joël Richard is currently Head of Technical & Pharmaceutical Operations at MedinCell (Montpellier, France). He is leading all the ph bronchodilators include Combiventum Take with Respimatium Take with nebulizer These medications are long-acting Long-acting bronchodilators are used regularly to open the airways and keep them open Lo PrEP. Against Vaginal SHIV Transmission in Macaques. Elena Bekerman*, . Derek Hansen, Bing Lu, Kelly Wang, William Rowe, . Federico Campigotto, Jim Zheng, Moupali Das, Christian Callebaut, Stephen R. Yant. Presented by Carol Nati MD, MS, DFAPA. Medical Director, MHMR of Tarrant County. Overview. Long Acting Injectable Antipsychotic Medications are underutilized in Texas.. They have been proven to work well.. Constance A. Benson, MD. Professor of Medicine and Global Public Health. University of California San Diego. La Jolla, California. Goals for the Workshop. To describe the potential benefits of long-acting antiretroviral drugs (ARVs) for treatment and prevention of HIV infection.